Compare Spyre Therapeutics Inc. Common Stock (SYRE) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Spyre Therapeutics Inc. Common Stock vs United Microelectronics Corp — how do they compare? Spyre Therapeutics Inc. Common Stock trades at $79.73 (market cap $7.35B), while United Microelectronics Corp trades at $20.28 (market cap $55.41B). The key difference: United Microelectronics Corp is far larger — about 7.5× Spyre Therapeutics Inc. Common Stock's market cap, and United Microelectronics Corp pays a 1.87% dividend while Spyre Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Spyre Therapeutics Inc. Common Stock for 0 Days and United Microelectronics Corp for 42 Days on average.
| SYRE | UMC | |
|---|---|---|
Market Cap | $7.35B | $55.41B |
Volume | 1,624,631 | 12,773,662 |
Sector | Health | Technology |
52-Week High | $108.92 | $28.02 |
52-Week Low | $22.18 | $7.02 |
Typical Hold Time | 0 Days | 42 Days |
Enterprise Value | $6.35B | $52.51B |
Dividend Yield | — | 1.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SYRE trades at $80.45, down 6.34% over 24 hours, with technical indicators showing neutral momentum near key support at $79. The clinical-stage biotech shows no revenue but maintains strong analyst support (92% buy rating) with a $119.89 consensus target. Recent positive SPY003 phase II ulcerative colitis data (Zacks, 2026-09-09) and a $350 million public offering (GlobeNewsWire, 2026-10-05) provide catalysts, though financials reflect pre-revenue challenges with a -197.71% net margin.
Investment outlook balances high-risk, high-reward potential. The robust pipeline in inflammatory bowel disease offers substantial upside if clinical successes continue, but the absence of revenue, negative cash flow from operations, and reliance on financing pose significant risks. Near-term price action will hinge on Q3 2026 earnings and further clinical updates.
UMC trades at $22.39, down 0.71% on the day, with a bullish technical signal but mixed moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.54 significantly exceeding the $0.16 estimate. Revenue for 2025 reached $237.55 billion, though net income margin has trended down from 32.1% in 2022 to 16.99% in 2025. Positive cash flow returned in 2025 at $5.66 billion after two years of outflows, and 2026 forecasts project improved profitability.
Outlook remains cautiously optimistic given earnings momentum and AI-driven demand, but risks include margin pressure, competitive threats, and market volatility. Analyst consensus is mixed with a 'Hold' rating predominant, yet some upgrades to Strong Buy highlight growth potential. The stock's valuation metrics suggest room for appreciation if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Spyre Therapeutics Inc. Common Stock
Spyre Therapeutics develops extended half-life antibody therapies for inflammatory bowel disease, including ulcerative colitis and Crohn's disease. Its pipeline targets pathways such as α4β7, TL1A, and IL-23 with antibodies engineered for infrequent subcutaneous dosing and potential combination use.
Read more on SYRE →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
